NEW YORK, October 13, 2017 /PRNewswire/ --
If you want a Stock Review on GEN, BKD, EVHC, or KND then come over to
Shares in Kennett Square, Pennsylvania headquartered Genesis Healthcare Inc. saw a slight decline of 0.98%, ending Thursday's trading session at $1.01. The stock recorded a trading volume of 162,881 shares. The Company's shares are trading 9.75% below their 50-day moving average. Moreover, shares of Genesis Healthcare, which together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the US, have a Relative Strength Index (RSI) of 41.03.
On September 18th, 2017, Genesis Rehab Services (GRS), a subsidiary of Genesis HealthCare, was honored by the Philadelphia Business Journal as a 2017 Health Care Innovator. GRS is a leading provider of physical, occupational, speech, and respiratory therapy services, primarily for the older adult population. Sarah Thomas, senior director of global innovation for GRS, accepted the award on the Company's behalf. Visit us today and access your complete report on GEN for free at:
Brookdale Senior Living
Brentwood, Tennessee headquartered Brookdale Senior Living Inc.'s stock declined 1.94%, closing the day at $10.11 with a total trading volume of 2.35 million shares. The stock is trading 12.99% below their 50-day moving average. Shares of the Company, which owns and operates senior living communities in the US, have an RSI of 28.10. The complimentary research report on BKD can be accessed at:
On Thursday, shares in Nashville, Tennessee-based Envision Healthcare Corp. recorded a trading volume of 2.38 million shares, which was higher than their three months average volume of 1.96 million shares. The stock ended the day 0.45% lower at $41.65. The Company's shares are trading below their 50-day moving average by 14.80%. Furthermore, shares of Envision Healthcare, which through its subsidiaries, provides various healthcare services in the US, have an RSI of 28.32.
On September 18th, 2017, Envision Healthcare announced the authorization of a program to repurchase up to $250 million of its common stock. The decision to return capital to shareholders reflects the Company's successful efforts to rationalize its service offerings around a physician-centric strategy and confidence in its ability to differentiate itself through its stated plan to drive operational excellence and long-term growth. Register for free on DailyStockTracker.com and download the research report on EVHC at:
Louisville, Kentucky headquartered Kindred Healthcare Inc.'s stock finished yesterday's session flat at $6.15 with a total trading volume of 781,459 shares. The stock is trading below their 50-day moving average by 14.98%. Shares of the Company, which provides healthcare services in the US, an RSI of 39.25.
On September 21st, 2017, research firm RBC Capital Markets reiterated its 'Sector Perform' rating on the Company's stock with a decrease of the target price from $9 a share to $7.50 a share.
On October 03rd, 2017, Kindred Healthcare announced that it will issue its Q3 2017 earnings release after the close of trading on November 06th, 2017. The Company will also host a conference call on November 07th, 2017, at 9:00 a.m. ET to cover its operating results. The live broadcast of the quarterly conference call will be available on the Company's website. Get free access to your research report on KND at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All